A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration

Control Delivery Systems

Status and phase: Unknown; Phase 2

Conditions: Macular Degeneration

Treatments: Drug: Retisert Implant

Study type: Interventional

Funder types: Industry

Identifiers

NCT00032396

CDS FL-004

Details and patient eligibility

About

A study evaluating Retisert in patients with age-related macular degeneration

Sex: All

Ages: 55+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria